
Bay Area Biotech Company Develops Promising New Class Of Drug To Treat COVID-19 Patients
A Bay Area biotechnology company has discovered a new way to make a COVID-19 treatment by producing an entirely new class of drugs. Soon, the invention will be tested in human clinical trials.